Skip to Main content Skip to Navigation
Conference papers

GNS561, A NEW ORAL CLINICAL-STAGE SMALL MOLECULE COMBINED WITH ANTI-PD1 SHOWED REMARKABLE ANTI-TUMOR EFFECTS IN A TRANSGENIC IMMUNOCOMPETENT HEPATOCELLULAR CARCINOMA MOUSE MODEL (ASV-B)

Complete list of metadatas

https://hal-amu.archives-ouvertes.fr/hal-02466433
Contributor : Isabelle Combe <>
Submitted on : Tuesday, February 4, 2020 - 2:30:18 PM
Last modification on : Wednesday, February 5, 2020 - 1:30:45 AM

Identifiers

  • HAL Id : hal-02466433, version 1

Collections

Citation

Rachid, Madani, Tijeras-Raballand, Annemilai, Cindy Serdjebi, Sonia Brun, Christelle Ansaldi, et al.. GNS561, A NEW ORAL CLINICAL-STAGE SMALL MOLECULE COMBINED WITH ANTI-PD1 SHOWED REMARKABLE ANTI-TUMOR EFFECTS IN A TRANSGENIC IMMUNOCOMPETENT HEPATOCELLULAR CARCINOMA MOUSE MODEL (ASV-B). Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Nov 2019, Boston, MA, United States. pp.1189A. ⟨hal-02466433⟩

Share

Metrics

Record views

30